Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Persistently active microbial molecules prolong innate immune tolerance in vivo.

Lu M, Varley AW, Munford RS.

PLoS Pathog. 2013 May;9(5):e1003339. doi: 10.1371/journal.ppat.1003339. Epub 2013 May 9.

2.

Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.

Lu M, Varley AW, Ohta S, Hardwick J, Munford RS.

Cell Host Microbe. 2008 Sep 11;4(3):293-302. doi: 10.1016/j.chom.2008.06.009.

3.

Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo.

Ojogun N, Kuang TY, Shao B, Greaves DR, Munford RS, Varley AW.

J Infect Dis. 2009 Dec 1;200(11):1685-93. doi: 10.1086/646616.

4.

The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens.

He YW, Li H, Zhang J, Hsu CL, Lin E, Zhang N, Guo J, Forbush KA, Bevan MJ.

Nat Immunol. 2004 Jan;5(1):88-97. Epub 2003 Dec 14.

5.

Initial responses to endotoxins and Gram-negative bacteria.

Heumann D, Roger T.

Clin Chim Acta. 2002 Sep;323(1-2):59-72. Review.

PMID:
12135807
6.

Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria.

Munford RS, Varley AW.

PLoS Pathog. 2006 Jun;2(6):e67. Review. No abstract available.

7.

The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo.

Lu M, Munford RS.

J Immunol. 2011 Sep 15;187(6):3314-20. doi: 10.4049/jimmunol.1004087. Epub 2011 Aug 17.

8.
9.

Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.

Alves-Rosa F, Vulcano M, Beigier-Bompadre M, Fernández G, Palermo M, Isturiz MA.

Clin Exp Immunol. 2002 May;128(2):221-8.

10.

The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.

Heumann D, Lauener R, Ryffel B.

J Endotoxin Res. 2003;9(6):381-4. Review.

PMID:
14733725
11.

Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria.

Tietze K, Dalpke A, Morath S, Mutters R, Heeg K, Nonnenmacher C.

J Periodontal Res. 2006 Oct;41(5):447-54.

PMID:
16953821
12.

Chapter 2: Kill the bacteria...and also their messengers?

Munford R, Lu M, Varley A.

Adv Immunol. 2009;103:29-48. doi: 10.1016/S0065-2776(09)03002-8. Review.

13.

Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.

Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA.

Infect Immun. 2004 Nov;72(11):6446-54.

14.

Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment.

Kanaan Z, Gardner S, Carruba C, Mattingly J, Druen D, Cheadle WG.

J Surg Res. 2012 Jun 15;175(2):289-97. doi: 10.1016/j.jss.2011.04.051. Epub 2011 May 19.

PMID:
21696761
15.

Recognition of gram-negative bacteria and endotoxin by the innate immune system.

Ulevitch RJ, Tobias PS.

Curr Opin Immunol. 1999 Feb;11(1):19-22. Review.

PMID:
10047547
16.

Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages.

Liang X, Lin T, Sun G, Beasley-Topliffe L, Cavaillon JM, Warren HS.

J Leukoc Biol. 2009 Aug;86(2):229-35. doi: 10.1189/jlb.1208742. Epub 2009 Apr 24.

17.

Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.

Zingarelli B, Fan H, Ashton S, Piraino G, Mangeshkar P, Cook JA.

Immunology. 2008 May;124(1):51-7. Epub 2007 Nov 17.

18.
19.

Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria.

Freudenberg MA, Merlin T, Gumenscheimer M, Kalis C, Landmann R, Galanos C.

Microbes Infect. 2001 Nov-Dec;3(14-15):1213-22. Review.

PMID:
11755409
20.

Regulation of an essential innate immune response by the p50 subunit of NF-kappaB.

Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ.

J Clin Invest. 1998 Nov 1;102(9):1645-52.

Supplemental Content

Support Center